Hu Y - Search Results

1

Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants.

Wu LS, Hu Y, Gane EJ, Slaets L, De Creus A, Ding Y, Niu J, Schwabe C, Goeyvaerts N, Xu Z, Huo D, Tuefferd M, Verbrugge I, Van Remoortere P, Schwertschlag U, Vandenbossche J. Wu LS, et al. Among authors: hu y. Antivir Ther. 2023 Feb;28(1):13596535231151626. doi: 10.1177/13596535231151626. Antivir Ther. 2023. PMID: 36691849 Free article.

2

Clinical evaluation of efficacy, tolerability and pharmacokinetics of yimitasvir phosphate in patients infected with hepatitis C virus.

Zhang H, Zhu X, Li Q, Lou J, Sun J, Shen Z, Chen H, Li X, Wu M, Li C, Liu J, Liu C, Hu Y, Wang J, Chen G, Ding Y, Niu J. Zhang H, et al. Among authors: hu y. J Pharm Pharmacol. 2018 Jul;70(7):855-864. doi: 10.1111/jphp.12916. Epub 2018 Apr 6. J Pharm Pharmacol. 2018. PMID: 29630721 Clinical Trial.

3

Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects.

Zhang H, Li Q, Zhu X, Li C, Li X, Liu C, Hu Y, Chen G, Wei H, Wang J, Shen Z, Ding Y. Zhang H, et al. Among authors: hu y. Cancer Chemother Pharmacol. 2018 Oct;82(4):615-623. doi: 10.1007/s00280-018-3645-1. Epub 2018 Jul 24. Cancer Chemother Pharmacol. 2018. PMID: 30043208 Clinical Trial.

4

Safety, pharmacokinetics and efficacy of donafenib in treating advanced hepatocellular carcinoma: report from a phase 1b trial.

Liu J, Li X, Zhang H, Chen G, Chen H, Hu Y, Niu J, Ding Y. Liu J, et al. Among authors: hu y. Pharmazie. 2019 Nov 1;74(11):688-693. doi: 10.1691/ph.2019.9626. Pharmazie. 2019. PMID: 31739839 Clinical Trial.

5

Safety, pharmacokinetics and pharmacodynamics of SYN023 alone or in combination with a rabies vaccine: An open, parallel, single dose, phase 1 bridging study in healthy Chinese subjects.

Ding Y, Wu M, Zhang H, Zhu X, Hu Y, Li X, Liu J, Tsao E, Liu M, Li C. Ding Y, et al. Among authors: hu y. Antiviral Res. 2020 Dec;184:104956. doi: 10.1016/j.antiviral.2020.104956. Epub 2020 Oct 19. Antiviral Res. 2020. PMID: 33091433 Clinical Trial.

6

Randomised clinical trial: safety, efficacy and pharmacokinetics of HS-10234 versus tenofovir for the treatment of chronic hepatitis B infection.

Zhang H, Hu Y, Wu M, Liu J, Zhu X, Li X, Chen H, Li C, Liu C, Niu J, Ding Y. Zhang H, et al. Among authors: hu y. Aliment Pharmacol Ther. 2021 Jan;53(2):243-252. doi: 10.1111/apt.16196. Epub 2020 Nov 28. Aliment Pharmacol Ther. 2021. PMID: 33249630 Clinical Trial.

7

Safety, pharmacokinetics and pharmacodynamics of TQ-A3334, an oral toll-like receptor 7 agonist in healthy individuals.

Hu Y, Zhang H, Wu M, Liu J, Li X, Zhu X, Li C, Chen H, Liu C, Niu J, Ding Y. Hu Y, et al. Expert Opin Investig Drugs. 2021 Mar;30(3):263-269. doi: 10.1080/13543784.2021.1873275. Epub 2021 Jan 13. Expert Opin Investig Drugs. 2021. PMID: 33405993 Clinical Trial.

8

Comparison of the Pharmacokinetics of Generic Versus Branded Obeticholic Acid in a Chinese Population: Effects of Food and Sex.

Li X, Zhang H, Li C, Zheng W, Wang M, Wu M, Yang D, Hu Y, Huo D, Xu Z, Ding Y, Liu L. Li X, et al. Among authors: hu y. Clin Pharmacol Drug Dev. 2021 Jul;10(7):797-806. doi: 10.1002/cpdd.905. Epub 2021 Jan 18. Clin Pharmacol Drug Dev. 2021. PMID: 33463088 Clinical Trial.

9

Pharmacokinetics and pharmacodynamics of MT-1207, a novel multitarget blocker of α1 receptor, 5-HT2A receptor, and calcium channel, in healthy subjects.

Zhang H, Wu M, Hu Y, Li C, Zheng W, Liu J, Li X, Zhu X, Ding Y. Zhang H, et al. Among authors: hu y. Expert Opin Investig Drugs. 2021 Mar;30(3):271-278. doi: 10.1080/13543784.2021.1887137. Epub 2021 Mar 3. Expert Opin Investig Drugs. 2021. PMID: 33560891 Clinical Trial.

10

Safety, tolerability, and pharmacokinetics of the novel pan-phosphodiesterase inhibitor ZSP1601 in healthy subjects: a double-blinded, placebo-controlled first-in-human single-dose and multiple-dose escalation and food effect study.

Zhu X, Wu M, Wang H, Li H, Lin J, Peng Y, Hu Y, Li C, Ding Y. Zhu X, et al. Among authors: hu y. Expert Opin Investig Drugs. 2021 May;30(5):579-589. doi: 10.1080/13543784.2021.1900822. Epub 2021 Mar 25. Expert Opin Investig Drugs. 2021. PMID: 33682556 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44,307 results

Search Page